Skip to main content

Table 1 Demographics and baseline characteristics of participants

From: Role of thymosin α1 in restoring immune response in immunological nonresponders living with HIV

Characteristic

N = 20 (%)

Sex

 Male

19 (95%)

 Female

1 (5%)

Median age, years (IQR)

48.1 (40.5, 57.0)

Nadir CD4 + T cell count (IQR, cells/μL)

22.0 (11.0, 109.0)

Nadir CD4/CD8 T-cell ratio (IQR, cells/μL)

0.06 (0.04, 0.18)

Viral load, > 2 years (copies/mL)

 < 50 (100%)

ART duration, years (IQR)

5.0 (3.0, 7.3)

Baseline CD4 + T cell count (IQR, cells/μL)

215.3 (190.1, 269.2)

Baseline CD4/CD8 T-cell ratio (IQR, cells/μL)

0.35 (0.24, 0.43)

ART regimens

 NRTIs + NNRTI

14 (70%)

 NRTIs

3 (15%)

 NRTIs + PI

2 (10%)

 NRTI + INSTI

1 (5%)

Past history

 Hyperlipidemia

6 (30%)

 Syphilis

3 (15%)

 Hypercholesterolemia

2 (10%)

 Hypertension

2 (10%)

 Uarthritis

2 (10%)

 Diabetes

1 (5%)

 Renal insufficiency

1 (5%)

 Hepatitis C infection

0 (0%)

  1. ART antiretroviral therapy, NRTI nucleoside reverse transcriptase inhibitor, NNRTI non-nucleoside reverse transcriptase inhibitor, PI protease inhibitor, INSTI integrase strand transfer inhibitors, IQR interquartile range